MEK-6, which stands for Mitogen-activated protein kinase kinase 6, is part of the intricate web of kinases responsible for cell signaling, particularly in the MAPK/ERK pathway. Activators of MEK-6 are chemical compounds that can stimulate or enhance the activity of this kinase, leading to increased downstream signal propagation. As the world of cellular biology delves deeper into the complexities of cellular communication, understanding the intricacies of how such activators operate becomes crucial. These activators can help scientists elucidate the underlying mechanisms of cellular functions, offering insights into various physiological processes.
The chemical structure and properties of MEK-6 activators can vary significantly. Some are small molecules, while others might be peptides or even larger compounds. The specificity of these activators for MEK-6 over other kinases is of paramount importance to ensure the targeted activation and reduce off-target effects. The interaction between the activator and MEK-6 typically involves binding to a specific site on the kinase, which in turn promotes its activity. This binding can either induce a conformational change in the protein structure, making it more receptive to substrate binding or can facilitate the interaction with other proteins in the signaling cascade. In research settings, the utilization of these activators allows for controlled activation of MEK-6, thereby helping to tease out its specific roles and interactions within the broader cellular signaling framework.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
This is a well-known MEK inhibitor, and while primarily targeting MEK1/2, its broader effects on the MAPK pathway could influence MEK6. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
This is a JNK activator that can also stimulate the p38 MAPK pathway, potentially influencing MEK6. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
A kinase inhibitor that targets several kinases, including some in the MAPK pathway, and might influence MEK6 activity. | ||||||
Doramapimod | 285983-48-4 | sc-300502 sc-300502A sc-300502B | 25 mg 50 mg 100 mg | $149.00 $281.00 $459.00 | 2 | |
A dual inhibitor of p38α and p38β MAP kinases. It could indirectly influence the activity of MEK6 due to its action on p38. | ||||||
Apigenin | 520-36-5 | sc-3529 sc-3529A sc-3529B sc-3529C sc-3529D sc-3529E sc-3529F | 5 mg 100 mg 1 g 5 g 25 g 100 g 1 kg | $33.00 $214.00 $734.00 $1151.00 $2348.00 $3127.00 $5208.00 | 22 | |
A natural product that has been shown to inhibit the MAPK pathway and could potentially influence MEK6. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $114.00 $166.00 $947.00 | 19 | |
A MEK inhibitor primarily targeting MEK1/2 but its broader effects on the MAPK pathway could influence MEK6. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
An inhibitor of Ras farnesyltransferase which may indirectly affect the Ras-Raf-MEK signaling cascade. | ||||||
ERK Inhibitor II, FR180204 | 865362-74-9 | sc-203945 sc-203945A sc-203945B sc-203945C | 1 mg 5 mg 10 mg 50 mg | $110.00 $165.00 $239.00 $942.00 | 45 | |
An ERK1/2 inhibitor which, by targeting a component of the MAPK pathway, might have implications for MEK6. | ||||||